Literature DB >> 2870502

Platelet aggregation caused by Carybdea rastonii toxins (CrTX-I, II and III) obtained from a jellyfish, Carybdea rastonii.

H Azuma, S Sekizaki, A Satoh, T Nakajima.   

Abstract

The pharmacological mechanisms of platelet aggregation induced by highly toxic proteins (CrTX-I, CrTX-II, and CrTX-III) obtained from tentacles of a jellyfish, Carybdea rastonii, were investigated. When the partially purified toxin (pCrTX) and CrTXs were added to the citrated platelet-rich plasma (PRP), aggregation was produced in a concentration-dependent manner. The activity of CrTXs was approximately 100 times more potent than pCrTX. The CrTXs-induced aggregation was little affected by indomethacin and quinacrine at concentrations sufficient to inhibit arachidonic acid- and collagen-induced aggregation. The CrTXs-induced aggregation in washed platelets was significantly augmented in the presence of Ca2+. The pretreatment with verapamil failed to modify this augmentation of aggregation. The concentration of cytoplasmic-free calcium ([Ca2+]i) of platelets was increased by CrTXs at the same concentrations that produced aggregation. This effect of CrTXs was again little affected by verapamil. CrTXs at the same concentrations as those that produced aggregation and increased [Ca2+]i caused depolarization of platelets, which was unchanged after pretreatment with sodium or potassium transport inhibitors. CrTX-I significantly increased the 22Na flux into platelets and this effect of CrTX-I was unaffected by tetrodotoxin. The CrTX-I-induced aggregation, depolarization, and increase in [Ca2+]i were all significantly attenuated in the low Na+ medium. These results suggest that CrTXs cause a massive depolarization by increasing cation permeability and this generalized depolarization permits an inward movement of Ca2+ down its electrochemical gradient which, in turn, triggers platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870502     DOI: 10.3181/00379727-182-42305

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  7 in total

Review 1.  Hemolytic venoms from marine cnidarian jellyfish - an overview.

Authors:  Gian Luigi Mariottini
Journal:  J Venom Res       Date:  2014-07-23

2.  Anticancer Effect of Nemopilema nomurai Jellyfish Venom on HepG2 Cells and a Tumor Xenograft Animal Model.

Authors:  Hyunkyoung Lee; Seong Kyeong Bae; Munki Kim; Min Jung Pyo; Minkyung Kim; Sujeoung Yang; Chung-Kil Won; Won Duk Yoon; Chang Hoon Han; Changkeun Kang; Euikyung Kim
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-13       Impact factor: 2.629

3.  Nemopilema nomurai jellyfish venom exerts an anti-metastatic effect by inhibiting Smad- and NF-κB-mediated epithelial-mesenchymal transition in HepG2 cells.

Authors:  Hyunkyoung Lee; Min Jung Pyo; Seong Kyeong Bae; Yunwi Heo; Indu Choudhary; Duhyeon Hwang; Hyeryeon Yang; Je-Hein Kim; Jinho Chae; Chang Hoon Han; Changkeun Kang; Seungshic Yum; Euikyung Kim
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

4.  Proteomic Analysis of Novel Components of Nemopilema nomurai Jellyfish Venom: Deciphering the Mode of Action.

Authors:  Indu Choudhary; Du Hyeon Hwang; Hyunkyoung Lee; Won Duk Yoon; Jinho Chae; Chang Hoon Han; Seungshic Yum; Changkeun Kang; Euikyung Kim
Journal:  Toxins (Basel)       Date:  2019-03-08       Impact factor: 4.546

5.  Successful treatment of jellyfish sting-induced severe digital ischemia with intravenous iloprost infusion.

Authors:  Arthur H Lo; Yiu Che Chan; Yuk Law; Stephen W Cheng
Journal:  J Vasc Surg Cases       Date:  2016-02-24

Review 6.  A Review of Toxins from Cnidaria.

Authors:  Isabella D'Ambra; Chiara Lauritano
Journal:  Mar Drugs       Date:  2020-10-06       Impact factor: 5.118

Review 7.  Cytotoxic and cytolytic cnidarian venoms. A review on health implications and possible therapeutic applications.

Authors:  Gian Luigi Mariottini; Luigi Pane
Journal:  Toxins (Basel)       Date:  2013-12-27       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.